Patients who have experienced treatment-resistant unipolar or bipolar depression and responded to a previous TMS course (response defined by a 50% reduction in MADRS score).
Sufficient command of French to complete questionnaires and follow instructions during MRI assessments and TMS treatments.
Willingness to comply with all study procedures, including availability for the duration of the study, and to communicate with study staff about adverse events and other clinically relevant information.
Patients who have expressed their informed written consent to participate in the study.
Person affiliated with a social welfare scheme or other scheme.
Current psychiatric comorbidity (suicidal risk, psychotic episode).
